As House leaders prepare to release a sweeping health overhaul plan, they're clinging to their goal to provide a liberal counterpoint to any legislation now likely to emerge from the Senate. On a broad array of contentious issues – from government’s role in providing insurance to the size of subsidies for lower-income Americans – the liberals who largely control the agenda in the House are holding fast to their principles. The legislation expected to be formally unveiled, perhaps as soon as today, will reflect their vision of how to insure nearly all Americans and how to pay for it – including a proposal to tax the wealthy that was announced Friday.
As House leaders prepare to release a sweeping health overhaul plan, they're clinging to their goal to provide a liberal counterpoint to any legislation now likely to emerge from the Senate.
On a broad array of contentious issues – from government’s role in providing insurance to the size of subsidies for lower-income Americans – the liberals who largely control the agenda in the House are holding fast to their principles. The legislation expected to be formally unveiled, perhaps as soon as today, will reflect their vision of how to insure nearly all Americans and how to pay for it – including a proposal to tax the wealthy that was announced Friday.
* Vaccine to be offered in fall if needed
* States need plan to close schools in worst case scenario
* Hospitals need surge capacity
HHS Secretary Kathleen Sebelius announced today that the department will commit $884 million to purchase additional supplies of two key ingredients for potential H1N1 vaccine to further prepare the nation for a potential resurgence of the 2009 H1N1 virus.
Total vaccine supply will depend on several other unknowns, including whether 15 micrograms of antigen is enough—as is the case with seasonal vaccine—and whether one or two shots are needed. A key factor is how many companies will use so-called adjuvants, which boost the immune response and thus lower the amount of antigen needed per shot. A recent survey among 36 vaccine producers, also presented by Kieny, showed that only 12 of the 33 proposed vaccine formulations will contain an adjuvant. Many companies have never used adjuvants and adding them now would raise additional safety issues, Kieny said. "It's very difficult to mix antigen from one company with adjuvant from another company when they have never been tested together."
More free home care guidance can be found here.
H1N1 swine flu attacks the respiratory system in a more sustained way than the standard seasonal virus, research in animals shows. Tests showed swine flu multiplies in greater numbers across the respiratory system, and causes more damage. And instead of staying in the head like seasonal flu, it penetrates deeper into the respiratory tissues - making it more likely to cause pneumonia. The University of Wisconsin study appears in the journal Nature.
H1N1 swine flu attacks the respiratory system in a more sustained way than the standard seasonal virus, research in animals shows.
Tests showed swine flu multiplies in greater numbers across the respiratory system, and causes more damage.
And instead of staying in the head like seasonal flu, it penetrates deeper into the respiratory tissues - making it more likely to cause pneumonia.
The University of Wisconsin study appears in the journal Nature.
New tests assessing brain changes and body chemistry are showing promise at diagnosing Alzheimer's disease in its earliest stages, aiding the search for new drugs, researchers said on Tuesday.